Abstract
Visceral leishmaniasis (VL) caused by Leishmania spp. is zoonotic. In many regions dogs serve as the predominant domestic reservoir of disease. This reservoir status has led to multiple efforts to control disease via reservoir control. Historically, public health-oriented strategies have focused on dog culling. Canine culling was established in Palestine in the 1940s and both China and former central republics of the Soviet Union in the 1950s. In these instances, with ample public health infrastructure funded by a centralized state, along with ability to use widespread spraying of DDT, VL transmission was halted but disease was not eradicated in any instance. Canine culling continues to be the predominant policy for VL control in Brazil, despite limited effectiveness. In well-developed countries of Europe with long average life expectancy and overall good health care, education, and nutrition, VL is predominantly found in immunocompromised patients. This is in spite of concurrently high levels of canine VL (cVL) in the same geographic locale. Similar trends are beginning to be seen in areas of rapid economic advancement within Brazil, demonstrating the importance of general health and environmental conditions in prevention of VL. As palatability for widespread canine culling wanes within areas endemic for cVL, combined alternate approaches including topical insecticides, reproductive control, and vaccination should be strongly considered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Alexander B, Barros VC et al (2009) Susceptibility to chemical insecticides of two Brazilian populations of the visceral leishmaniasis vector Lutzomyia longipalpis (Diptera: Psychodidae). Trop Med Int Health 14(10):1272–1277
Alvar J, Canavate C et al (1997) Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 10(2):298–319
Alvar J, Velez ID et al (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7(5):e35671
Amro A, Schonian G et al (2009) Population genetics of Leishmania infantum in Israel and the Palestinian Authority through microsatellite analysis. Microbes Infect 11(4):484–492
Aresu L, Valenza F et al (2007) Membranoproliferative glomerulonephritis type III in a simultaneous infection of Leishmania infantum and Dirofilaria immitis in a dog. J Vet Diagn Invest 19(5):569–572
Barreto ML, Teixeira MG et al (2011) Successes and failures in the control of infectious diseases in Brazil: social and environmental context, policies, interventions, and research needs. Lancet 377(9780):1877–1889
Boggiatto PM, Gibson-Corley KN et al (2011) Transplacental transmission of Leishmania infantum as a means for continued disease incidence in North America. PLoS Negl Trop Dis 5(4):e1019
Borja-Cabrera GP, Correia Pontes NN et al (2002) Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN). Vaccine 20(27–28):3277–3284
Cortese L, Terrazzano G et al (2011) Prevalence of anti-platelet antibodies in dogs naturally co-infected by Leishmania infantum and Ehrlichia canis. Vet J 188(1):118–121
Costa CH (2011) How effective is dog culling in controlling zoonotic visceral leishmaniasis? A critical evaluation of the science, politics and ethics behind this public health policy. Rev Soc Bras Med Trop 44(2):232–242
Coura-Vital W, Marques MJ et al (2011) Prevalence and factors associated with Leishmania infantum infection of dogs from an urban area of Brazil as identified by molecular methods. PLoS Negl Trop Dis 5(8):e1291
Courtenay O, Kovacic V et al (2009) A long-lasting topical deltamethrin treatment to protect dogs against visceral leishmaniasis. Med Vet Entomol 23(3):245–256
da Silva VO, Borja-Cabrera GP et al (2000) A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN). Vaccine 19(9–10):1082–1092
Dantas-Torres F (2006) Leishmune vaccine: the newest tool for prevention and control of canine visceral leishmaniosis and its potential as a transmission-blocking vaccine. Vet Parasitol 141(1–2):1–8
Dantas-Torres F, Solano-Gallego L et al (2012) Canine leishmaniosis in the Old and New Worlds: unveiled similarities and differences. Trends Parasitol 28(12):531–538
de Almeida AS, Medronho Rde A et al (2011) Identification of risk areas for visceral leishmaniasis in Teresina, Piaui State, Brazil. Am J Trop Med Hyg 84(5):681–687
Duthie MS, Raman VS et al (2012) The development and clinical evaluation of second-generation leishmaniasis vaccines. Vaccine 30(2):134–141
Esch KJ, Pontes NN et al (2012) Preventing zoonotic canine leishmaniasis in northeastern Brazil: pet attachment and adoption of community leishmania prevention. Am J Trop Med Hyg 87(5):822–831
Gavgani AS, Hodjati MH et al (2002) Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Lancet 360(9330):374–379
Gradoni L (2001) An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine. Vet Parasitol 100(1–2):87–103
Hamarsheh O, Nasereddin A et al (2012) Serological and molecular survey of Leishmania parasites in apparently healthy dogs in the West Bank, Palestine. Parasit Vectors 5:183
Harhay MO, Olliaro PL et al (2011a) Urban parasitology: visceral leishmaniasis in Brazil. Trends Parasitol 27(9):403–409
Harhay MO, Olliaro PL et al (2011b) Who is a typical patient with visceral leishmaniasis? Characterizing the demographic and nutritional profile of patients in Brazil, East Africa, and South Asia. Am J Trop Med Hyg 84(4):543–550
Jimenez M, Gonzalez E et al (2013) Detection of Leishmania infantum and identification of blood meals in Phlebotomus perniciosus from a focus of human leishmaniasis in Madrid, Spain. Parasitol Res 112(7):2453–2459
Kovalenko DA, Razakov SA et al (2011) Canine leishmaniosis and its relationship to human visceral leishmaniasis in Eastern Uzbekistan. Parasit Vectors 4:58
Lemesre JL, Holzmuller P et al (2005) Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Vaccine 23(22):2825–2840
Lima ID, Queiroz JW et al (2012) Leishmania infantum chagasi in northeastern Brazil: asymptomatic infection at the urban perimeter. Am J Trop Med Hyg 86(1):99–107
Martins VT, Chavez-Fumagalli MA et al (2013) Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis. PLoS Negl Trop Dis 7(3):e2148
Mencke N, Volf P et al (2003) Repellent efficacy of a combination containing imidacloprid and permethrin against sand flies (Phlebotomus papatasi) in dogs. Parasitol Res 90(suppl 3):S108–S111
Molina R, Gradoni L et al (2003) HIV and the transmission of Leishmania. Ann Trop Med Parasitol 97(suppl 1):29–45
Moreno J, Alvar J (2002) Canine leishmaniasis: epidemiological risk and the experimental model. Trends Parasitol 18(9):399–405
Mutinga MJ, Renapurkar DM et al (1993) A bioassay to evaluate the efficacy of permethrin-impregnated screens used against phlebotomine sandflies (Diptera: Psychodidae) in Baringo District of Kenya. East Afr Med J 70(3):168–170
Nunes CM, Pires MM et al (2010) Relationship between dog culling and incidence of human visceral leishmaniasis in an endemic area. Vet Parasitol 170(1–2):131–133
Oliveira TM, Furuta PI et al (2008) A study of cross-reactivity in serum samples from dogs positive for Leishmania sp., Babesia canis and Ehrlichia canis in enzyme-linked immunosorbent assay and indirect fluorescent antibody test. Rev Bras Parasitol Vet 17(1):7–11
Otranto D, Dantas-Torres F (2010) Canine and feline vector-borne diseases in Italy: current situation and perspectives. Parasit Vectors 3:2
Otranto D, Dantas-Torres F (2013) The prevention of canine leishmaniasis and its impact on public health. Trends Parasitol 29(7):339–345
Otranto D, Paradies P et al (2007) Efficacy of a combination of 10% imidacloprid/50% permethrin for the prevention of leishmaniasis in kennelled dogs in an endemic area. Vet Parasitol 144(3–4):270–278
Otranto D, de Caprariis D et al (2010) Prevention of endemic canine vector-borne diseases using imidacloprid 10% and permethrin 50% in young dogs: a longitudinal field study. Vet Parasitol 172(3–4):323–332
Otranto D, Dantas-Torres F et al (2013) Prevention of canine leishmaniosis in a hyper-endemic area using a combination of 10% imidacloprid/4.5% flumethrin. PLoS One 8(2):e56374
Paape D, Aebischer T (2011) Contribution of proteomics of Leishmania spp. to the understanding of differentiation, drug resistance mechanisms, vaccine and drug development. J Proteomics 74(9):1614–1624
Pagliano P, Carannante N et al (2005) Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature. J Antimicrob Chemother 55(2):229–233
Palatnik-de-Sousa CB, Silva-Antunes I et al (2009) Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas. Vaccine 27(27):3505–3512
Queiroz PV, Monteiro GR et al (2009) Canine visceral leishmaniasis in urban and rural areas of Northeast Brazil. Res Vet Sci 86(2):267–273
Quinnell RJ, Courtenay O (2009) Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis. Parasitology 136(14):1915–1934
Raman VS, Duthie MS et al (2012) Adjuvants for Leishmania vaccines: from models to clinical application. Front Immunol 3:144
Ribeiro VM, da Silva SM et al (2013) Control of visceral leishmaniasis in Brazil: recommendations from Brasileish. Parasit Vectors 6(1):8
Romero GA, Boelaert M (2010) Control of visceral leishmaniasis in Latin America—a systematic review. PLoS Negl Trop Dis 4(1):e584
Tabbara KS (2006) Progress towards a Leishmania vaccine. Saudi Med J 27(7):942–950
Talmi-Frank D, Kedem-Vaanunu N et al (2010) Leishmania tropica infection in Golden Jackals and Red Foxes, Israel. Emerg Infect Dis 16(12):1973–1975
Tasca KI, Buzetti WA et al (2009) Parasitological, immunohistochemical and histopathological study for Leishmania chagasi detection in splenic tissues of dogs with visceral leishmaniasis. Rev Bras Parasitol Vet 18(1):27–33
Tesh RB (1995) Control of zoonotic visceral leishmaniasis: is it time to change strategies? Am J Trop Med Hyg 52(3):287–292
Trigo J, Abbehusen M et al (2010) Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE. Vaccine 28(19):3333–3340
Vanloubbeeck Y, Jones DE (2004) The immunology of Leishmania infection and the implications for vaccine development. Ann N Y Acad Sci 1026:267–272
Werneck GL (2008) Forum: geographic spread and urbanization of visceral leishmaniasis in Brazil. Introduction. Cad Saude Publica 24(12):2937–2940
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Petersen, C.A., Esch, K.J. (2014). Reservoir Control Strategies for Leishmaniasis: Past, Present, and Future. In: Satoskar, A., Durvasula, R. (eds) Pathogenesis of Leishmaniasis. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9108-8_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9108-8_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9107-1
Online ISBN: 978-1-4614-9108-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)